TY  - JOUR
AU  - Carcedo-Rodriguez, David
AU  - Artola-Urain, Teresa
AU  - Chinea-Rodriguez, Anabelle
AU  - Garcia-Torres, Estefania
AU  - Gonzalez-Vicent, Marta
AU  - Gutierrez-Garcia, Gonzalo
AU  - Regueiro-Garcia, Alexandra
AU  - Calvo-Hidalgo, Marcos
AU  - Villacampa, Alba
PY  - 2021
DO  - 10.1080/13696998.2021.1916749
UR  - http://hdl.handle.net/10668/17586
T2  - Journal of medical economics
AB  - This study evaluated cost-effectiveness of defibrotide vs best supportive care (BSC) for the treatment of hepatic veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) with multiorgan dysfunction (MOD) post-hematopoietic cell...
LA  - en
PB  - Taylor & Francis
KW  - Defibrotide
KW  - E20
KW  - I00
KW  - Spain
KW  - Cost-effectiveness
KW  - Multiorgan dysfunction
KW  - Sinusoidal obstruction syndrome
KW  - Veno-occlusive disease
KW  - Cost-Benefit Analysis
KW  - Fibrinolytic Agents
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hepatic Veno-Occlusive Disease
KW  - Humans
KW  - Polydeoxyribonucleotides
KW  - Spain
TI  - Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain.
TY  - research article
VL  - 24
ER  -